المؤلفون: Jiao C; Department of Radiation Oncology, UC San Francisco, San Francisco, CA 94143, United States of America., Lao Y; Department of Radiation Oncology, UC Los Angeles, Los Angeles, CA 90095, United States of America., Zhang W; Department of Radiation Oncology, UC San Francisco, San Francisco, CA 94143, United States of America., Braunstein S; Department of Radiation Oncology, UC San Francisco, San Francisco, CA 94143, United States of America., Salans M; Department of Radiation Oncology, UC San Francisco, San Francisco, CA 94143, United States of America., Villanueva-Meyer J; Department of Radiology and Biomedical Imaging, UC San Francisco, San Francisco, CA 94143, United States of America., Hervey-Jumper SL; Department of Neurosurgery, UC San Francisco, San Francisco, CA 94143, United States of America., Yang B; Department of Radiation Oncology, UC San Francisco, San Francisco, CA 94143, United States of America., Morin O; Department of Radiation Oncology, UC San Francisco, San Francisco, CA 94143, United States of America., Valdes G; Department of Radiation Oncology, UC San Francisco, San Francisco, CA 94143, United States of America., Fan Z; Department of Radiology, University of Southern California, Los Angeles, CA 90033, United States of America., Shiroishi M; Department of Radiology, University of Southern California, Los Angeles, CA 90033, United States of America., Zada G; Department of Neurosurgery, University of Southern California, Los Angeles, CA 90033, United States of America., Sheng K; Department of Radiation Oncology, UC San Francisco, San Francisco, CA 94143, United States of America., Yang W; Department of Radiation Oncology, UC San Francisco, San Francisco, CA 94143, United States of America.

المصدر: Physics in medicine and biology [Phys Med Biol] 2024 Jul 25; Vol. 69 (15). Date of Electronic Publication: 2024 Jul 25.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: IOP Publishing Country of Publication: England NLM ID: 0401220 Publication Model: Electronic Cited Medium: Internet ISSN: 1361-6560 (Electronic) Linking ISSN: 00319155 NLM ISO Abbreviation: Phys Med Biol Subsets: MEDLINE

مواضيع طبية MeSH: Glioblastoma*/diagnostic imaging , Glioblastoma*/pathology , Magnetic Resonance Imaging* , Brain Neoplasms*/diagnostic imaging , Brain Neoplasms*/pathology , Neoplasm Recurrence, Local*/diagnostic imaging, Humans ; Image Processing, Computer-Assisted/methods ; Neural Networks, Computer ; Retrospective Studies ; Recurrence ; Male ; Female ; Middle Aged

المؤلفون: Mehrbakhsh Z; Department of Biostatistics, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran.; Student Research Committee, Hamadan University of Medical Sciences, Hamadan, Iran., Tapak L; Department of Biostatistics, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran.; Modeling of Noncommunicable Diseases Research Center, Hamadan University of Medical Sciences, Hamadan, Iran., Behnampour N; Department of Biostatistics and Epidemiology, School of Health, Golestan University of Medical Sciences, Gorgan, Iran., Roshanaei G; Department of Biostatistics, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran.; Modeling of Noncommunicable Diseases Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.

المصدر: Journal of research in health sciences [J Res Health Sci] 2024 Jun 01; Vol. 24 (2), pp. e00615. Date of Electronic Publication: 2024 Jun 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Hamadan University of Medical Sciences, School of Public Health, distributed by Elsevier Country of Publication: Iran NLM ID: 101480094 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2228-7809 (Electronic) Linking ISSN: 22287795 NLM ISO Abbreviation: J Res Health Sci Subsets: MEDLINE

مواضيع طبية MeSH: Recurrence*, Humans ; Child ; Male ; Female ; Retrospective Studies ; Child, Preschool ; Risk Factors ; Adolescent ; Infant ; Prognosis ; Iran/epidemiology ; Leukemia/mortality ; Leukemia/therapy ; Infant, Newborn ; Models, Statistical ; Leukemia, Myeloid, Acute/mortality ; Proportional Hazards Models ; Neoplasm Recurrence, Local ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/mortality ; Platelet Count

المؤلفون: Chaix J; Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France., Schleiermacher G; INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Research Center, PSL Research University, Institut Curie, Paris, France; SIREDO Oncology Center (Care, Innovation and Research for Children and AYA with Cancer), Institut Curie, PSL Research University, Paris, France., Corradini N; Department of Pediatric Oncology, Institut d'Hématologie et d'Oncologie Pédiatrique/Centre Léon Bérard, Lyon, France., André N; Department of Pediatric Hematology and Oncology, Hôpital de La Timone, AP-HM, Marseille, France; UMR Inserm 1068, CNRS UMR 7258, Aix Marseille Université U105, Marseille Cancer Research Center (CRCM), Marseille, France., Thebaud E; Department of Pediatric Oncology, Centre Hospitalier Universitaire, Nantes, France., Gambart M; Department of Pediatric Oncology, Centre Hospitalier Universitaire, Toulouse, France., Defachelles AS; Department of Pediatric Oncology, Centre Oscar Lambret, Lille, France., Entz-Werle N; Department of Pediatric Oncology, Hospices Civils de Strasbourg, Strasbourg, France., Chastagner P; Department of Pediatric Oncology, Centre Hospitalier Universitaire, Vandoeuvre les Nancy, France., De Carli É; Department of Pediatric Oncology, Centre Hospitalier Universitaire, Angers, France., Ducassou S; Department of Pediatric Oncology, Centre Hospitalier Universitaire, Bordeaux, France., Landman-Parker J; Sorbonne Université APHP, Hôpital A Trousseau Paris, Paris, France., Adam-de-Beaumais T; Clinical Research Direction, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France., Larive A; Biostatistics and Epidemiology Office, Gustave Roussy Cancer Campus, INSERM U1018, CESP, Université Paris-Saclay, Villejuif, France., Michiels S; Biostatistics and Epidemiology Office, Gustave Roussy Cancer Campus, INSERM U1018, CESP, Université Paris-Saclay, Villejuif, France., Vassal G; Clinical Research Direction, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France., Valteau-Couanet D; Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France., Geoerger B; Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France; INSERM U1015, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France., Berlanga P; Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France. Electronic address: Pablo.Berlanga@gustaveroussy.fr.

المصدر: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Apr; Vol. 201, pp. 113923. Date of Electronic Publication: 2024 Feb 15.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasm Recurrence, Local*/drug therapy , Neoplasm Recurrence, Local*/genetics , Neuroblastoma*/drug therapy , Neuroblastoma*/genetics, Humans ; Prospective Studies ; Chronic Disease ; Recurrence

المؤلفون: Conconi A; Division of Hematology, Ospedale degli Infermi, Biella, Italy., Chiappella A; Haematology Unit, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy., Ferreri AJM; Lymphoma Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy., Stathis A; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland., Botto B; SC Ematologia, AOU Città della Salute e della Scienza di Torino, Turin, Italy., Sassone M; Lymphoma Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy., Gaidano G; SCDU Ematologia, Department of Translational Medicine, University of Eastern Piedmont and AOU Maggiore della Carità, Novara, Italy., Balzarotti M; UO Ematologia, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy., Merli F; Hematology Unit, Azienda USL-IRCCS of Reggio Emilia, Reggio Emilia, Italy., Tucci A; Division of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy., Vanazzi A; Division of Clinical Haemato-Oncology, European Institute of Oncology IRCCS, Milan, Italy., Tani M; UO Ematologia, Dipartimento Oncologia ed Ematologia, Ospedale Santa Maria delle Croci, Ravenna, Italy., Bruna R; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland., Orsucci L; Lymphoma Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy., Cabras MG; Ospedale Oncologico, Ematologia e CTMO, Cagliari, Italy., Celli M; Ospedale degli Infermi, Hematology Unit, Rimini, Italy., Annibali O; Area Ematologia Medicina Trasfusionale e Terapia cellulare Policlinico Universitario Campus Bio-Medico, Rome, Italy., Liberati AM; SC Oncoematologia, Azienda Ospedaliera Santa Maria, Università degli studi di Perugia, Terni, Italy., Zanni M; Antonio e Biagio e Cesare Arrigo Hospital, Hematology Unit, Alessandria, Italy., Ghiggi C; IRCCS Ospedale Policlinico San Martino UO Ematologia e Terapie Cellulari, Genoa, Italy., Pisani F; Hematology and Stem Cell Transplantation Unit, IRCCS Istituto Nazionale dei Tumori Regina Elena, Rome, Italy., Pinotti G; Ospedale di Circolo, Oncologia Medica, Varese, Italy., Dore F; AOU di Sassari, Sassari, Italy., Esposito F; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland., Pirosa MC; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.; Institute of Oncology Research, Bellinzona, Switzerland., Cesaretti M; Fondazione Italiana Linfomi ONLUS, Modena, Italy., Bonomini L; Institute of Oncology Research, Bellinzona, Switzerland., Vitolo U; Medical Oncology, Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia-IRCCS, Candiolo, Turin, Italy., Zucca E; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland.; Institute of Oncology Research, Bellinzona, Switzerland.

المصدر: Blood advances [Blood Adv] 2024 Mar 26; Vol. 8 (6), pp. 1541-1549.

نوع المنشور: Clinical Trial, Phase II; Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasm Recurrence, Local*/prevention & control , Neoplasm Recurrence, Local*/drug therapy , Lymphoma, Large B-Cell, Diffuse*/drug therapy , Lymphoma, Large B-Cell, Diffuse*/pathology, Male ; Adult ; Humans ; Aged ; Antibodies, Monoclonal, Murine-Derived ; Rituximab/therapeutic use ; Methotrexate/therapeutic use ; Cytarabine/adverse effects ; Recurrence

المؤلفون: Capozzi VA; Department of Medicine and Surgery, University Hospital of Parma, Parma, 43125, Italy., Monfardini L; Department of Medicine and Surgery, University Hospital of Parma, Parma, 43125, Italy., Maglietta G; Clinical and Epidemiological Research Unit, University Hospital of Parma, 43125, Parma, Italy. Electronic address: gmaglietta@ao.pr.it., Barresi G; Department of Medicine and Surgery, University Hospital of Parma, Parma, 43125, Italy., De Finis A; Department of Medicine and Surgery, University Hospital of Parma, Parma, 43125, Italy., Rosati A; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Vargiu V; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Cosentino F; Department of Medicine and Health Sciences, University of Molise Studies, Campobasso, Italy; Department of Oncology, Gemelli Molise Spa, Campobasso, Italy., Sozzi G; Department of Gynecologic Oncology, University of Palermo, 90127, Palermo, Italy., Chiantera V; Department of Gynecologic Oncology, University of Palermo, 90127, Palermo, Italy., Bogani G; Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy., Carnelli M; Division of Gynecology and Obstetrics, ASST Papa Giovanni XXIII, Bergamo, Italy., Scambia G; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Fanfani F; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Ghi T; Department of Medicine and Surgery, University Hospital of Parma, Parma, 43125, Italy., Berretta R; Department of Medicine and Surgery, University Hospital of Parma, Parma, 43125, Italy.

المصدر: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2024 Mar; Vol. 50 (3), pp. 107985. Date of Electronic Publication: 2024 Jan 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 8504356 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2157 (Electronic) Linking ISSN: 07487983 NLM ISO Abbreviation: Eur J Surg Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasm Recurrence, Local*/pathology , Endometrial Neoplasms*/surgery , Endometrial Neoplasms*/pathology, Female ; Humans ; Retrospective Studies ; Neoplasm Staging ; Crime ; Recurrence ; Lymph Node Excision

المؤلفون: Cadena-Piñeros E; Department of Head and Neck Surgery, Instituto Nacional de Cancerología, Bogotá, DC, Colombia.; Department of Otorhinolaryngology, Universidad Nacional de Colombia and Hospital Universitario Nacional de Colombia, Bogotá, DC, Colombia., Correa-Marin J; Department of Head and Neck Surgery, Instituto Nacional de Cancerología, Bogotá, DC, Colombia., Llamas-Olier A; Nuclear Medicine Department, Instituto Nacional de Cancerología, Bogotá, DC, Colombia., de Los Reyes A; Nuclear Medicine Department, Instituto Nacional de Cancerología, Bogotá, DC, Colombia., Vallejo MT; Clinical and Epidemiologic Cancer Research Group, Instituto Nacional de Cancerología, Bogotá, DC, Colombia.

المصدر: Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery [Clin Otolaryngol] 2024 Mar; Vol. 49 (2), pp. 270-276. Date of Electronic Publication: 2023 Nov 29.

نوع المنشور: Observational Study; Journal Article

بيانات الدورية: Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 101247023 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1749-4486 (Electronic) Linking ISSN: 17494478 NLM ISO Abbreviation: Clin Otolaryngol Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasm Recurrence, Local*/diagnostic imaging , Neoplasm Recurrence, Local*/surgery , Neoplasm Recurrence, Local*/pathology , Thyroid Neoplasms*/diagnostic imaging , Thyroid Neoplasms*/surgery, Humans ; Reoperation ; Retrospective Studies ; Reproducibility of Results ; Recurrence

المؤلفون: Vittayawacharin P; Hematopoietic Stem Cell Transplantation and Cellular Therapy Program, Division of Hematology/Oncology, Department of Medicine, University of California, Irvine, Orange, California, USA., Kongtim P; Hematopoietic Stem Cell Transplantation and Cellular Therapy Program, Division of Hematology/Oncology, Department of Medicine, University of California, Irvine, Orange, California, USA., Chu Y; Department of Pediatrics, New York Medical College, Valhalla, New York, USA., June CH; Department of Pathology and Laboratory Medicine, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Bollard CM; Center for Cancer and Immunology Research, Children's National Hospital and The George Washington University, Washington, DC, USA., Ciurea SO; Hematopoietic Stem Cell Transplantation and Cellular Therapy Program, Division of Hematology/Oncology, Department of Medicine, University of California, Irvine, Orange, California, USA.

المصدر: American journal of hematology [Am J Hematol] 2024 May; Vol. 99 (5), pp. 910-921. Date of Electronic Publication: 2024 Jan 25.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasm Recurrence, Local*/etiology , Hematopoietic Stem Cell Transplantation*/methods, Humans ; T-Lymphocytes ; Killer Cells, Natural ; Recurrence ; Immunotherapy, Adoptive/methods ; Antigens, CD19

المؤلفون: Lin K; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Chowdhury S; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Zeineddine MA; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Zeineddine FA; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Hornstein NJ; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Villarreal OE; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Maru DM; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Haymaker CL; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Vauthey JN; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Chang GJ; Department of Colon and Rectal Surgery, The University of Texas-MD Anderson Cancer Center, Houston, Texas., Bogatenkova E; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Menter D; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kopetz S; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Shen JP; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

المصدر: Molecular cancer research : MCR [Mol Cancer Res] 2024 Apr 02; Vol. 22 (4), pp. 337-346.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101150042 Publication Model: Print Cited Medium: Internet ISSN: 1557-3125 (Electronic) Linking ISSN: 15417786 NLM ISO Abbreviation: Mol Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasm Recurrence, Local*/pathology , Colorectal Neoplasms*/pathology, Humans ; Gene Expression Profiling ; Recurrence ; Sequence Analysis, RNA ; Neoplastic Stem Cells/metabolism ; Cell Line, Tumor

المؤلفون: Bouvarel B; Surgical Oncology, Institut de Cancerologie de l'Ouest, Saint Herblain, France., Colomban O; University Claude Bernard Lyon 1, Lyon, France., Frenel JS; Medical Oncology, Institut de Cancerologie de l'Ouest, Saint Herblain, France., Loaec C; Surgical Oncology, Institut de Cancerologie de l'Ouest, Saint Herblain, France., Bourgin C; Surgical Oncology, Institut de Cancerologie de l'Ouest, Saint Herblain, France., Berton D; Medical Oncology, Institut de Cancerologie de l'Ouest, Saint Herblain, France., Freyer G; Medical Oncology, Hospices Civils de Lyon, Lyon, France., You B; Medical Oncology, Hospices Civils de Lyon, Lyon, France., Classe JM; Surgical Oncology, Institut de Cancerologie de l'Ouest, Saint Herblain, France Jean-Marc.Classe@ico.unicancer.fr.

المصدر: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2024 Apr 01; Vol. 34 (4), pp. 574-580. Date of Electronic Publication: 2024 Apr 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BMJ Country of Publication: England NLM ID: 9111626 Publication Model: Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int J Gynecol Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasm Recurrence, Local*/drug therapy , Ovarian Neoplasms*/drug therapy , Ovarian Neoplasms*/surgery , Ovarian Neoplasms*/pathology, Humans ; Female ; Retrospective Studies ; Carcinoma, Ovarian Epithelial/surgery ; Neoadjuvant Therapy ; CA-125 Antigen ; Recurrence ; Cytoreduction Surgical Procedures ; Chemotherapy, Adjuvant

المؤلفون: Nachmias B; Department of Hematology, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel., Aumann S; Department of Hematology, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel., Haran A; Department of Hematology, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel., Schimmer AD; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

المصدر: British journal of haematology [Br J Haematol] 2024 Apr; Vol. 204 (4), pp. 1146-1158. Date of Electronic Publication: 2024 Jan 31.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasm Recurrence, Local*/drug therapy , Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/metabolism , Sulfonamides*, Humans ; Aged ; Proto-Oncogene Proteins c-bcl-2/genetics ; Proto-Oncogene Proteins c-bcl-2/metabolism ; Bridged Bicyclo Compounds, Heterocyclic/pharmacology ; Bridged Bicyclo Compounds, Heterocyclic/therapeutic use ; Recurrence ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/pharmacology